semaglutide or tirzepatide better for weight loss vs 2026: 22% vs 15% Guide GLP-1 Medications for Weight Loss:

Enzyme Inhibitors : Soybean Peptide Inhibits collagenase and elastase degradation

Enhancing insulin sensitivity and fat metabolism GLP-1 receptor agonists enhance insulin secretion and suppress glucagon release, helping to better control blood sugar levels

Other efficacy outcomes at 104 weeks included: A 40% reduction in uACR with semaglutide versus 12% with placebo

They said more studies are needed to fully understand how these medications influence mental health over time

FDA, DOH warn public vs unauthorized glutathione use The Food and Drug Administration (FDA) said it only approves glutathione products with indications related to the treatment of "cisplatin chemotherapy" in response to concerns regarding a reported fatality associated with the use of glutathione